Jewish Hospital, Cincinnati
Findings describe new data in cardiology research
Published in Cardiovascular Business Week, March 14th, 2006
Study 1: Diltiazem prophylaxis significantly lowers the risk of atrial fibrillation after heart bypass surgery.
Cardiovascular surgeons in the United States conducted a study "to evaluate the prophylactic effect of diltiazem on the incidence of atrial arrhythmia (fibrillation and/or flutter) following coronary artery bypass grafting (CABG)."
"Data were retrospectively gathered," noted N. Dobrilovic and coauthors working at the Jewish Hospital in Cincinnati. "Patients undergoing elective CABG by one surgeon at one institution over a 3-year period were...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
More Articles from Cardiovascular Business Week
- Aastrom Biosciences, Inc.
Aastrom Biosciences provides clinical pipeline update, financial results - Cambridge Heart, Inc.
Cambridge Heart reports 21.9% decrease in revenue - CardioDynamics
CardioDynamics reports 21% decrease in sales - CardioTech International, Inc.
CardioTech International reports 3.9% increase in revenue - Conor Medsystems, Inc.
Vascular drug-delivery company reports Q4 net loss of $20.1 million - Heartscape Technologies, Inc.
Heartscape closes $3M series A financing - More from this issue of Cardiovascular Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
